Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |